circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis
暂无分享,去创建一个
Xinming Zhao | Xiaolin Chen | Weipeng Lv | Lihua Liu | Yan Zhao | Y. Jia | Jiali Wang | Jing Han | S. Zhen | Shuxian Yin | Fan Yu | Jiaqi Wang | Fan Xu
[1] S. Gerstberger,et al. Metastasis , 2023, Cell.
[2] Ruimin Huang,et al. Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance. , 2023, Cancer research.
[3] W. Fan,et al. Epithelial cells activate fibroblasts to promote esophageal cancer development. , 2023, Cancer cell.
[4] Rushikesh S. Joshi,et al. Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects , 2023, The Journal of clinical investigation.
[5] L. Stegger,et al. Fibroblast Activation Protein triggers release of drug payload from non-internalizing small molecule-drug conjugates in solid tumors. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] Yuhe Huang,et al. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis , 2022, Journal of Hematology & Oncology.
[7] Yueping Liu,et al. Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer , 2022, Journal of Cancer Research and Clinical Oncology.
[8] R. Kalluri,et al. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL-6 Mediated Therapy Resistance in Pancreatic Cancer. , 2022, Cancer discovery.
[9] Quanbo Zhou,et al. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway , 2022, Journal of experimental & clinical cancer research : CR.
[10] D. Hanahan. Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.
[11] Zihua Wang,et al. Fibroblast Activation Protein-α Responsive Peptide Assembling Prodrug Nanoparticles for Remodeling the Immunosuppressive Microenvironment and Boosting Cancer Immunotherapy. , 2021, Small.
[12] J. Kjems,et al. The emerging roles of circRNAs in cancer and oncology , 2021, Nature Reviews Clinical Oncology.
[13] Lihua Liu,et al. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin , 2021, Molecular Cancer.
[14] R. Kalluri,et al. Clinical and therapeutic relevance of cancer-associated fibroblasts , 2021, Nature Reviews Clinical Oncology.
[15] Q. Zhan,et al. NOX5 mediates the crosstalk between tumor cells and cancer‐associated fibroblasts via regulating cytokine network , 2021, Clinical and translational medicine.
[16] N. Almog,et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. , 2021, Cancer cell.
[17] A. Orimo,et al. Phenotypic heterogeneity, stability and plasticity in tumor‐promoting carcinoma‐associated fibroblasts , 2021, The FEBS journal.
[18] Hua Wu,et al. Comparison of 68Ga-FAPI and 18F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers. , 2020, Radiology.
[19] L. Liu,et al. LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1. , 2020, European review for medical and pharmacological sciences.
[20] J. Kjems,et al. Spatial expression analyses of the putative oncogene ciRS-7 in cancer reshape the microRNA sponge theory , 2020, Nature Communications.
[21] D. Ma,et al. hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p/CREBRF axis. , 2020, Epigenomics.
[22] L. Weiner,et al. The role of fibroblast activation protein in health and malignancy , 2020, Cancer and Metastasis Reviews.
[23] Gary D Bader,et al. Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21 , 2020, The Journal of experimental medicine.
[24] Yihai Cao,et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation , 2020, Nature Communications.
[25] Jian-hua Zhou,et al. microRNA‐30a attenuates TGF‐β1–induced activation of pulmonary fibroblast cell by targeting FAP‐α , 2020, Journal of cellular and molecular medicine.
[26] T. Watabe,et al. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models , 2019, The Journal of Nuclear Medicine.
[27] P. Robson,et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. , 2019, Cancer discovery.
[28] L. Butler,et al. Cancer-associated fibroblasts—heroes or villains? , 2019, British Journal of Cancer.
[29] X. Cui,et al. Autocrine TGF-β1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation. , 2019, Cancer letters.
[30] Toshio Tanaka,et al. Targeting Interleukin-6 Signaling in Clinic. , 2019, Immunity.
[31] H. Kauczor,et al. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer , 2019, The Journal of Nuclear Medicine.
[32] R. Brekken,et al. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer , 2019, Molecular Cancer.
[33] G. Ullenhag,et al. First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies , 2019, International journal of cancer.
[34] Xiao-Hua Cheng,et al. The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[35] Xuetao Cao,et al. Characteristics and Significance of the Pre-metastatic Niche. , 2016, Cancer cell.
[36] C. Gaggioli,et al. Fibroblast activation in cancer: when seed fertilizes soil , 2016, Cell and Tissue Research.
[37] S. Nam,et al. Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer , 2015, Cell Death and Differentiation.
[38] S. Rosenberg,et al. Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia , 2013, The Journal of experimental medicine.
[39] James O. Jones,et al. Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia , 2013, The Journal of experimental medicine.
[40] D. Kranz. Faculty Opinions recommendation of Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. , 2010 .
[41] James O. Jones,et al. Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α , 2010, Science.
[42] C. Garlanda,et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. , 1997, The American journal of pathology.
[43] L. Old,et al. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets. , 1986, Cancer research.